The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph Boesecke

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

STI Diagnostics in the CEE Region - Pawel Jakubowski

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

2020: Have We Reached the 90-90-90 Targets? - Teymur Noori

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

HIV and COVID-19 co-infection: An update Cristiana Oprea

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers? Prof. Milosz Parczewski

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? Con Standpoint - Jürgen Rockstroh

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Gilleece, Yvonne - The Management of Hepatitis in Pregnancy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract Book - CEE Meeting on Viral Hepatitis and HIV 2020

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract Book - European Meeting on HIV & Hepatitis 2020

European Meeting on HIV & Hepatitis 2020

Reinfection With Hepatitis C Virus: Clinical Case Reports And Literature Review

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Characteristics Of Women Diagnosed With HIV In The WHO European Region And Predictors Of Late Diagnosis

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

A Pilot Study Of The Acceptability And Feasibility Of HCV Self-Testing Among Key Populations In Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Evidence Of Experience In Community-Based HCV Treatment Among HIV/HCV Co-Infected PWIDs In Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Quality Of Lives Of PLWHA From Baylor Clinic In Constanta, Romania Decreased During The COVID-19 Pandemic

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Coinfection With Hepatitis Viruses In Patients With HIV Infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Development Of Structural Changes In Patients Treated For VHC In The Czech Republic From Viewpoint Of Stage Of Liver Fibrosis, HCV Genotype, Age And Treatment Strategy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Recent Insights Into Risk Factors For HBV Vertical Transmission

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

The Level Of Alexithymia In HIV-Positive Patients With Drug Addiction

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Seroprevalence Of Hepatitis E Virus In Rural Residents In Northern Vietnam

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Investigation Of Viral Genome Diversity And Treatment Response With Next Generation Sequencing Technology During Interferon Treatment Of Patients With Chronic Hepatitis Delta

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020